Latest News and Press Releases

LOS ANGELES, July 30, 2026 (GLOBE NEWSWIRE) -- RankWell Legal, an independent awards and recognition program honoring distinguished attorneys and law firms across the United States, today announced...

Regulated information Half-year report on Pluxee N.V.’s liquidity contract as of June 30, 2026 Pursuant to the liquidity contract entered into by Pluxee N.V. with BNP Paribas, the following assets...

Information réglementée Bilan semestriel du contrat de liquidité de Pluxee N.V. au 30 juin 2026 Au titre du contrat de liquidité confié par la société Pluxee N.V. à BNP Paribas, en date de...

Agios announces that the FDA has accepted its sNDA for mitapivat in sickle cell disease with a Priority Review

SupplySide Global 2026 expands to three expo hall days (Oct 28–30) at Mandalay Bay, featuring 1,600+ exhibitors, and new 'Pick Your Path' education format

LOS ANGELES, July 01, 2026 (GLOBE NEWSWIRE) -- SupplyTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout technology companies, products...

SUNRISE-FA 2 study parameters include LVMI primary endpoint, 6-month topline efficacy analysis, inclusion criteria focused on abnormal baseline LVMI and open-label trial design  BLA supportive...

Longeveron (LGVN) granted Small or Medium-sized Enterprise (SME) status by the European Medicines Agency (EMA).

Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System

PYRUKYND (mitapivat) approved in the European Union for adults with thalassemia